Detalhe da pesquisa
1.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
N Engl J Med
; 385(1): 35-45, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192430
2.
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials.
Clin Gastroenterol Hepatol
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806372
3.
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
Int J Mol Sci
; 24(13)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445994
4.
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
J Hepatol
; 74(2): 321-329, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950590
5.
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Gastroenterology
; 159(5): 1672-1685.e5, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721437
6.
Distribution of histopathological features along the colon in microscopic colitis.
Int J Colorectal Dis
; 36(1): 151-159, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920702
7.
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Gastroenterology
; 157(1): 74-86.e15, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922997
8.
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
Gastroenterology
; 155(6): 1795-1804.e3, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195447
9.
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 17(1): 98-106.e4, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29702300
10.
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
J Hepatol
; 67(3): 549-558, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529147
11.
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.
Gut
; 65(3): 390-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25792708
12.
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Gut
; 65(1): 47-56, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425655
13.
Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Gastroenterology
; 146(5): 1222-30.e1-2, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440672
14.
Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits.
Int J Exp Pathol
; 96(3): 151-62, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25716348
15.
Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).
BMC Gastroenterol
; 14: 197, 2014 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425214
16.
Mesalazine granules promote disease clearance in patients with mild-to-moderate ulcerative colitis.
United European Gastroenterol J
; 11(8): 775-783, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490352
17.
Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Biol Blood Marrow Transplant
; 18(1): 134-40, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703973
18.
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Gastroenterology
; 140(2): 425-434.e1; quiz e13-4, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21070781
19.
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme.
United European Gastroenterol J
; 10(3): 330-343, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412032
20.
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
J Crohns Colitis
; 16(11): 1714-1724, 2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709376